Clinical trial
Assessment of the Renoprotective Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
NCT05966818 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Renoprotective Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
- Lead sponsor
- Ain Shams University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 1, 2023
- Completion date
- March 1, 2024
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.